Oncology Services for Seniors: Cancer Screening, Treatment, and Supportive Care

Cancer is, statistically speaking, a disease of aging. The National Cancer Institute reports that the median age at cancer diagnosis in the United States is 66 — meaning older adults sit squarely at the center of oncology care, not at its edges. This page covers how cancer screening, treatment, and supportive services function specifically for seniors, what distinguishes geriatric oncology from standard cancer care, and how families and care coordinators can navigate the decision points that arise when a cancer diagnosis intersects with age-related health complexity.

Definition and scope

Geriatric oncology is the subspecialty focused on cancer diagnosis and treatment in adults typically aged 65 and older, accounting for the physiological, functional, and social factors that change with age. It is distinct from standard oncology not because the tumors behave differently — though sometimes they do — but because the person carrying the tumor does.

Adults 65 and older account for approximately 60% of all new cancer diagnoses in the United States, according to National Cancer Institute SEER data. That concentration means oncology services are already deeply embedded in senior care, even when they aren't labeled as such.

The scope of oncology services for seniors includes three interlocking components:

1. Cancer screening — age-appropriate surveillance for breast, colorectal, lung, prostate, and skin cancers, calibrated against life expectancy and functional status rather than applied as a blanket protocol.
2. Active treatment — surgery, chemotherapy, radiation, immunotherapy, targeted therapy, or combinations, modified based on what an older patient's body can realistically tolerate.
3. Supportive care — symptom management, nutrition support, cognitive monitoring, mental health services, and coordination with hospice and palliative care when curative intent gives way to comfort as the primary goal.

How it works

The starting point in geriatric oncology is a Comprehensive Geriatric Assessment (CGA), a structured evaluation that goes beyond the standard oncology workup. The CGA examines functional status, cognitive ability, nutritional state, fall risk, polypharmacy burden, and social support — all of which affect a patient's capacity to tolerate treatment and recover from it.

The American Society of Clinical Oncology (ASCO) published a clinical practice guideline recommending CGA for all older adults with cancer before making treatment decisions (ASCO Geriatric Oncology Guideline, Journal of Clinical Oncology, 2018). The rationale is straightforward: a 74-year-old who walks 2 miles a day and manages five medications independently has a fundamentally different risk profile than a 74-year-old with early dementia, moderate frailty, and limited social support — even if the tumor type and stage are identical.

Screening decisions follow a different logic for seniors than for younger adults. The U.S. Preventive Services Task Force (USPSTF), whose guidelines inform most clinical screening protocols, ties recommendations explicitly to age thresholds and individual health context. Colorectal cancer screening, for instance, is recommended through age 75, with individualized decision-making from 76 to 85, and generally not recommended past 85 — a framework that reflects diminishing benefit relative to procedural risk as functional reserve declines (USPSTF Colorectal Cancer Screening Recommendation).

Medication management becomes especially critical during active oncology treatment. Chemotherapy agents interact with common medications taken for hypertension, diabetes, and cardiovascular disease — conditions that affect the majority of cancer patients over 70. Oncology pharmacists in geriatric programs review drug interactions that general practitioners may not flag.

Common scenarios

Three patterns appear with notable frequency in senior oncology:

Early-stage cancer with curative treatment. A 68-year-old with early-stage lung cancer and strong functional status may be an excellent candidate for surgery or stereotactic radiation. The care team coordinates with primary care providers and, depending on post-treatment needs, with skilled nursing facility care for short-term rehabilitation after major procedures.

Advanced cancer with treatment-plus-support. A 79-year-old with metastatic colorectal cancer may receive chemotherapy calibrated to a lower dose intensity than standard protocols — a practice called dose modification — while also receiving concurrent palliative support for pain, fatigue, and appetite loss. The goal here is extending meaningful quality of life, not necessarily length of life, and the distinction matters enormously when families are making decisions about care settings.

Frailty-driven transition to supportive-only care. An 84-year-old with significant frailty and a new cancer diagnosis may, after full assessment and family discussion, choose to forgo aggressive treatment entirely. In these cases, the oncology team hands primary coordination to palliative and hospice specialists. This is not giving up — it is, as geriatricians often describe it, a different kind of treatment, one focused on what the patient actually values. Families navigating this moment often benefit from resources on having the senior care conversation.

Decision boundaries

The hardest questions in geriatric oncology are not medical — they are definitional. What counts as benefit? Whose values drive the plan?

A structured way to approach these boundaries:

1. Establish life expectancy context. Treatment decisions that make sense for a patient with a 10-year life expectancy may cause net harm for a patient with a 2-year life expectancy due to unrelated conditions.
2. Assess functional trajectory. Is the patient stable, declining slowly, or in rapid decline? Treatment that a stable patient tolerates may accelerate decline in a frail one.
3. Clarify goals of care. Cure, life extension, and comfort are not always compatible. ASCO and the American Geriatrics Society both recommend explicit goals-of-care conversations before initiating cancer treatment in older adults.
4. Coordinate across care settings. Cancer treatment does not happen in oncology offices alone. It intersects with in-home senior care, assisted living, and chronic condition management in ways that require active coordination rather than parallel tracking.
5. Revisit regularly. A patient's functional status and goals may change during treatment. A plan that was appropriate at diagnosis may need revision after the first treatment cycle.

The 60% figure — 60% of cancer diagnoses occurring in adults over 65 — makes one thing structurally clear: oncology is not an exceptional detour in senior care. For a large share of older adults, it is simply part of the landscape, and navigating it well requires the same careful, individualized assessment that defines good senior care needs assessment at every other decision point in aging.